Reinforcing strength of a novel dopamine transporter ligand: Pharmacodynamic and pharmacokinetic mechanisms

Journal of Pharmacology and Experimental Therapeutics

Volumn 303, Issue 1, 2002, Pages 211-217

  Woolverton, W L ^a   Ranaldi, R ^a   Wang, Z ^b   Ordway, G A ^a   Paul, I A ^a   Petukhov, P ^b   Kozikowski, A ^a  

^a UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

^b GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE TRANSPORTER; LIGAND;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOPAMINE UPTAKE; DOPAMINERGIC TRANSMISSION; DOSE RESPONSE; DRUG POTENCY; NEUROTRANSMITTER RELEASE; NONHUMAN; NORADRENALIN RELEASE; PRIORITY JOURNAL; RECEPTOR BLOCKING; RECEPTOR OCCUPANCY; REINFORCEMENT; RHESUS MONKEY; STRENGTH;

ANIMALS; COCAINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; DOSE-RESPONSE RELATIONSHIP, DRUG; KINETICS; LIGANDS; MACACA MULATTA; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; MOLECULAR STRUCTURE; NERVE TISSUE PROTEINS; NOREPINEPHRINE PLASMA MEMBRANE TRANSPORT PROTEINS; PIPERIDINES; SELF ADMINISTRATION; SYMPORTERS;

EID: 0036786404     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.102.037812     Document Type: Article

References (40)

1. Balster RL and Schuster CR (1973) Fixed-interval schedule of cocaine reinforcement: effect of dose and infusion duration. J Exp Anal Behav 20:199-129.
2. Bergman J, Madras BK, Johnson SE, and Spealman RD (1989) Effects of cocaine and related drugs in nonhuman primates: self-administration by squirrel monkeys. J Pharmacol Exp Ther 251:150-155.
3. Carroll FI, Kotian P, Dehghani A, Gray JL, Kuzemko MA, Parham KA, Abraham P, Lewin AH, Boja JW, and Kuhar MJ (1995) Cocaine and 3β-(4′-substituted phenyl)tropane-2β-carboxylic acid ester and amide analogues. New high-affinity and selective compounds for the dopamine transporter. J Med Chem 38:379-388.
4. Carroll FI, Howell LL, and Kuhar MJ (1999) Pharmacotherapies for treatment of cocaine abuse: preclinical issues. J Med Chem 42:2721-2736.
5. deWit H, Dudish S, and Ambre J (1993) Subjective and behavioral effects of diazepam depend on its rate of onset. Psychopharmacology 112:324-330.
6. Gatley SJ, Volkow ND, Gifford AN, Fowler JS, Dewey SL, Ding Y-S, and Logan J (1999) Dopamine-transporter occupancy after intravenous doses of cocaine and methylphenidate in mice and humans. Psychopharmacology 146:93-100.
7. Gorelick DA (1997) The rate hypothesis and agonist substitution approaches to cocaine abuse treatment. Adv Pharmacol 42:995-997.
8. Howell LL and Byrd LD (1991) Characterization of the effects of cocaine and GBR 12909, a dopamine uptake inhibitor, on behavior in the squirrel monkey. J Pharmacol Exp Ther 258:178-185.
9. Howell LL and Wilcox KM (2001) The dopamine transporter and cocaine medication development: drug self-administration in nonhuman primates. J Pharmacol Exp Ther 298:1-6.
10. Katz JL (1990) Models of relative reinforcing efficacy and their predictive utility. Behav Pharmacol 1:283-301.
11. Kozikowski AP, Araldi GL, Boja J, Meil WM, Johnson KM, Flippen-Anderson JL, George C, and Saiah E (1998) Chemistry and pharmacology of the piperidine-based analogues of cocaine. Identification of potent DAT inhibitors lacking the tropane skeleton. J Med Chem 41:1962-1969.
12. Lewis DB, Matecka D, Zhang Y, Hsin L, Dersch CM, Stafford D, Glowa JR, Rothman RB, and Rice KC (1999) Oxygenated analogues of 1-[2-(diphenylmethoxy)ethyl]-and 1-[2-[bis(4-fluorophanyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazines (GBR 12935 and GBR 12909) as potential extended-action cocaine-abuse therapeutic agents. J Med Chem 42:5029-5042.
13. Marsch LA, Bickel WK, Badger GJ, Rathmell JP, Swedberg MDB, Jonzon B, and Norsten-Hoog C (2001) Effects of infusion rate of intravenously administered morphine on physiological, psychomotor and self-reported measures in humans. J Pharmacol Exp Ther 299:1056-1065.
14. Mello NK and Negus SS (1996) Preclinical evaluation of pharmacotherapies for treatment of cocaine and opioid abuse using drug self-administration procedures. Neuropsychopharmacology 14:375-424.
15. Newman AH (1998) Novel dopamine transporter ligands: the state of the art. Med Chem Res 8:1-11.
16. Petukhov PA, Wang CZ, Ye YP, Johnson KM, Tella SR, and Kozikowski AP (2002) SAR studies of piperidine-based analogues of cocaine. 4: Effect of N-modification and ester replacement. J Med Chem 45:3161-3170.
17. 3H]WIN 35,428 binding to dopamine uptake sites in vivo more rapidly than mazindol or GBR 12909. Eur J Pharmacol 198:203-205.
18. Ranaldi R, Anderson KG, Carroll FI, and Woolverton WL (2000) Reinforcing and discriminative stimulus effects of RTI 111, a 3-phenyltropane analog, in rhesus monkeys: interaction with methamphetamine. Psychopharmacology 153:103-110.
19. Ranaldi R and Woolverton WL (2002) Self-administration of cocaine: scopolamine combinations by rhesus monkeys. Psychopharmacology 161:442-448.
20. Richardson NR and Roberts DCS (1996) Progressive ratio schedules in drug self-administration studies in rats: a method to evaluate reinforcing efficacy. J Neurosci Methods 66:1-11.
21. Ritz MC, Lamb RJ, Goldberg SR, and Kuhar MJ (1987) Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science (Wash DC) 237:1219-1223.
22. Roberts DCS, Phelan R, Hodges LM, Hodges MM, Bennett B, Childers S, and Davies H (1999) Self-administration of cocaine analogs by rats. Psychopharmacology 144:389-397.
23. 3H]WIN 35,428. J Pharmacol Exp Ther 257:954-958.
24. Skjoldager P, Winger G, and Woods JH (1993) Effects of GBR 12909 and cocaine on cocaine-maintained behavior in rhesus monkeys. Drug Alcohol Depend 33:31-39.
25. Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, Fujimoto EK, Goeke NM, Olson BJ, and Klenk DC (1985) Measurement of protein using bicinchoninic acid. Anal Biochem 150:76-85.
26. Snider RS and Lee JC (1961) A Stereotaxic Atlas of the Monkey Brain, University of Chicago Press, Chicago.
27. Spealman RD, Madras BK, and Bergman J (1989) Effects of cocaine and related drugs in nonhuman primates. II. Stimulant effects on schedule-controlled behavior. J Pharmacol Exp Ther 251:142-149.
28. Stafford D, LeSage MG, and Glowa JR (1998) Progressive-ratio schedules of drug delivery in the analysis of drug self-administration: a review. Psychopharmacology 139:169-184.
29. Stafford D, LeSage MG, Rice KC, and Glowa JR (2001) A comparison of cocaine, GBR 12909 and phentermine self-administration by rhesus monkeys on a progressive-ratio schedule. Drug Alcohol Depend 62:41-47.
30. Stathis M, Scheffel U, Lever SZ, Boja JW, Carroll FI, and Kuhar MJ (1995) Rate of binding of various inhibitors at the dopamine transporter in vivo. Psychopharmacology 119:376-384.
31. 2 receptors. J Pharmacol Exp Ther 266:1374-1384.
32. Tella SR, Ladenheim B, Andrews AM, Goldberg SR, and Cadet JL (1996) Differential reinforcing effects of cocaine and GBR-12909: biochemical evidence for divergent neuroadaptive changes in the mesolimbic dopaminerigic system. J Neurosci 16: 7416-7427.
33. Vanover KE, Nader MA, and Woolverton WL (1992) Evaluation of the discriminative stimulus reinforcing effects of sertraline in rhesus monkeys. Pharmacol Biochem Behav 41:789-793.
34. Volkow ND, Wang GJ, Fischman MW, Foltin RW, Fowler JS, Abumrad NN, Vitkun S, Logan J, Gatley SJ, Pappas N, Hitzemann R, and Shea CE (1997) Relationship between subjective effects of cocaine and dopamine transporter occupancy. Nature (Lond) 386:827-830.
35. Volkow ND, Wang G-J, Fowler JS, Gatley SJ, Ding Y-S, Logan J, Dewey SL, Hitzemann R, and Lieberman J (1996) Relationship between psychostimulant-induced "high" and dopamine transporter occupancy. Proc Natl Acad Sci USA 93:10388-10392.
36. Wilcox KM, Lindsey KP, Votaw JR, Goodman MM, Martarello L, Carroll FI, and Howell LL (2002) Self-administration of cocaine and the cocaine analog RTI-113: relationship to dopamine transporter occupancy determined by PET neuroimaging in rhesus monkeys. Synapse 43:78-85.
37. Wilcox KM, Rowlett JK, Paul IA, Ordway GA, and Woolverton WL (2000) On the relationship between the dopamine transporter and the reinforcing effects of local anesthetics in rhesus monkeys: practical and theoretical concerns. Psychopharmacology 153:139-147.
38. Woolverton WL, Hecht GS, Agoston GE, Katz JL, and Newman AH (2001) Further studies of the reinforcing effects of benztropine analogs in rhesus monkeys. Psychopharmacology 154:375-382.
39. Woolverton WL and Ranaldi R (2002) Comparison of the reinforcing efficacy of two dopamine D2-like receptor agonists in rhesus monkeys using a progressive-ratio schedule of reinforcement. Pharmacol Biochem Behav 72:803-809.
40. Woolverton WL, Rowlett JK, Wilcox KM, Paul IA, Kline RH, Newman AH, and Katz JL (2000) 3′- and 4′-Chloro-substituted analogs of benztropine: intravenous self-administration and in vitro radioligand binding studies in rhesus monkeys. Psychopharmacology 147:426-435.